EmpiRx Health is challenging the status quo in today`s pharmacy benefit management industry by offering evidence-based clinical care programs that are aligned with our member`s needs. Our concierge model along with our proactive oversight and agile technology platform provide actionable insight to protect our clients and their members from ever-rising drug costs.
Ameronc Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SameSky Health is a developer of a patient engagement platform intended to connect payers, providers, and health systems with multi-cultural Medicare patient populations. The company`s platform addresses the needs of clients with multi-cultural populations through web and application-based integrated services including multi-channel messaging, care navigation, and data insights and consultancy. It was formerly known as ConsejoSano and changed it`s name to SameSky Health. The company was founded in 2017 and is based in North Hollywood, California.
Anthera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including exocrine pancreatic insufficiency due to cystic fibrosis, lupus, lupus with glomerulonephritis, and IgA nephropathy.
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.